The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, March 25, 2020
Ampio is preparing an expanded access FDA protocol to study potential benefit of nebulized treatment with Ampion in COVID-19 induced ARDS.
read more
Wednesday, March 25, 2020
The FDA approved a supplemental application for Epclusa (sofosbuvir and velpatasvir) to treat hepatitis C virus in children ages 6 years and older.
read more
Novartis and a consortium of life sciences companies announced a collaboration to accelerate the development, manufacture and delivery of vaccines, ...
read more
AstraZeneca Pharmaceuticals
AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in Japan for the treatment of patients with hyperkalaemia.
read more
ANI has submitted a PAS to the Endocrinology Division at the FDA for re-commercialization of Purified Cortrophin Gel.
read more
Partner Therapeutics announced Leukine® is being assessed in the SARPAC trial at University Hospital Ghent for respiratory illness associated with ...
read more
Mind Medicine announced the company has begun enrollment in further human safety studies of 18-MC, the company's orally-active drug candidate for the ...
read more
Relief Therapeutics and NeuroRx have filed an IND Application with the FDA for a phase 2 trial of Aviptadil for Acute and Moderate Respiratory ...
read more
Altasciences has completed a Phase I study for the development of gimsilumab for SARS CoV-2 in patients with or at risk of developing acute ...
read more
Wednesday, April 01, 2020
FibroGenesis announced the filing of United States Provisional Patent Number 63/002,134 titled, "Peptides and Adjuvants for Augmentation of Fibroblast...
read more
Wednesday, April 01, 2020
The FDA stood up a new program to expedite the development of potentially safe and effective life-saving treatments.
read more
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020.
read more
The FDA has approved durvalumab in combination with etoposide and either carboplatin or cisplatin as first-line treatment of patients with ES-SCLC.
read more
Hydroxychloroquine sulphate an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity ...
read more
Review the latest news and information on the COVID-19 Pandemic.
read more